Sciessent Medical Blog

It’s no surprise that HAIs are taking a toll on U.S. healthcare. Many of these infections are caused by antibiotic-resistant bacteria and impact more than two million people each year. The implications for quality care – not to mention the financial and regulatory penalties for hospitals – are ...

An average of two million people becoming ill with antibiotic-resistant infections each year in the U.S. – and surfaces, including medical devices, are a common source of these infections. Because of that, healthcare is turning to antimicrobial-treated medical devices and surfaces to combat ...

Readers of the Sciessent blog know that clinical data has proven the effectiveness of some antimicrobials in killing dangerous strains of bacteria and reducing the risk of infection. But one of the most common questions that we get about antimicrobials is around how exactly they work.

At Sciessent, we work heavily within the healthcare space – helping manufacturers bring their antimicrobial-treated devices to market. Not only do we provide the antimicrobial technologies, but we’re also very involved throughout the lifecycle of the product – from design, development and testing ...

While we discussed three of the four challenges/best practices for incorporating antimicrobials onto the surfaces of medical devices in our last post, we left the last and perhaps most complex topic for its own blog. This is the wild world of regulatory approval.

The statistic is startling: More than two million people become ill with antibiotic-resistant infections each year. Many of these organisms are the cause of healthcare-associated infections (HAIs), which impact one in 25 patients in the U.S. annually. These infections claim the lives of 75,000 ...